Rubella

Published on 27/03/2015 by admin

Filed under Pediatrics

Last modified 27/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1522 times

Chapter 239 Rubella

Rubella (German measles or 3-day measles) is a mild, often exanthematous disease of infants and children that is typically more severe and associated with more complications in adults. Its major clinical significance is transplacental infection and fetal damage as part of the congenital rubella syndrome (CRS).

Epidemiology

In the prevaccine era, rubella appeared to occur in major epidemics every 6-9 yr, with smaller peaks interspersed every 3-4 yr, and was most common in preschool and school-aged children. Following introduction of the rubella vaccine, the incidence fell by >99%, with a relatively higher percentage of infections reported among persons >19 yr of age. After years of decline, a resurgence of rubella and CRS occurred during 1989-1991 (Fig. 239-1). Subsequently, a 2-dose recommendation for rubella vaccine was implemented and resulted in a decrease in incidence of rubella from 0.45/100,000 in 1990 to 0.1/100,000 in 1999 and a corresponding decrease of CRS, with an average of 6 infants with CRS reported annually from 1992 to 2004. Mothers of these infants tended to be young, Hispanic, or foreign born. The number of reported cases of rubella continued to decline in the early part of this decade.

image

Figure 239-1 Number of confirmed rubella cases and percentage coverage with first dose of measles-containing vaccine—the Americas, 1996–2008.*

(From Centers for Disease Control and Prevention: Progress toward elimination of rubella and congenital rubella syndrome—the Americas, 2003–2008, MMWR Morb Mortal Wkly Rep 2008;57:1176–1179, 2008.)

Pathology

Little information is available on the pathologic findings in rubella occurring postnatally. The few reported studies of biopsy or autopsy material from cases of rubella revealed only nonspecific findings of lymphoreticular inflammation and mononuclear perivascular and meningeal infiltration. The pathologic findings for CRS are often severe and may involve nearly every organ system (Table 239-1).

Table 239-1 PATHOLOGIC FINDINGS IN CONGENITAL RUBELLA SYNDROME

SYSTEM PATHOLOGIC FINDINGS
Cardiovascular Patent ductus arteriosus
Pulmonary artery stenosis
Ventriculoseptal defect
Myocarditis
Central nervous system Chronic meningitis
Parenchymal necrosis
Vasculitis with calcification
Eye Microphthalmia
Cataract
Iridocyclitis
Ciliary body necrosis
Glaucoma
Retinopathy
Ear Cochlear hemorrhage
Endothelial necrosis
Lung Chronic mononuclear interstitial pneumonitis
Liver Hepatic giant cell transformation
Fibrosis
Lobular disarray
Bile stasis
Kidney Interstitial nephritis
Adrenal gland Cortical cytomegaly
Bone Malformed osteoid
Poor mineralization of osteoid
Thinning cartilage
Spleen, lymph node Extramedullary hematopoiesis
Thymus Histiocytic reaction
Absence of germinal centers
Skin Erythropoiesis in dermis

Pathogenesis

The viral mechanisms for cell injury and death in rubella are not well understood for either postnatal or congenital infection. Following infection, the virus replicates in the respiratory epithelium, then spreads to regional lymph nodes (Fig. 239-2). Viremia ensues and is most intense from 10 to 17 days after infection. Viral shedding from the nasopharynx begins about 10 days after infection and may be detected up to 2 wk following onset of the rash. The period of highest communicability is from 5 days before to 6 days after the appearance of the rash.

image

Figure 239-2 Pathophysiologic events in postnatally acquired rubella virus infection. *Possible complications include arthralgia and/or arthritis, thrombocytopenic purpura, and encephalitis.

(From Lamprecht CL: Rubella virus. In Beshe RB, editor: Textbook of human virology, ed 2, Littleton, MA, 1990, PSG Publishing, p 685.)

The most important risk factor for severe congenital defects is the stage of gestation at the time of infection. Maternal infection during the 1st 8 wk of gestation results in the most severe and widespread defects. The risk for congenital defects has been estimated at 90% for maternal infection before 11 wk of gestation, 33% at 11-12 wk, 11% at 13-14 wk, and 24% at 15-16 wk. Defects occurring after 16 wk of gestation are uncommon, even if fetal infection occurs.

Causes of cellular and tissue damage in the infected fetus may include tissue necrosis due to vascular insufficiency, reduced cellular multiplication time, chromosomal breaks, and production of a protein inhibitor causing mitotic arrests in certain cell types. The most distinctive feature of congenital rubella is chronicity. Once the fetus is infected early in gestation, the virus persists in fetal tissue until well beyond delivery. Persistence suggests the possibility of ongoing tissue damage and reactivation, most notably in the brain.

Clinical Manifestations

Postnatal infection with rubella is a mild disease not easily discernible from other viral infections, especially in children. Following an incubation period of 14-21 days, a prodrome consisting of low-grade fever, sore throat, red eyes with or without eye pain, headache, malaise, anorexia, and lymphadenopathy begins. Suboccipital, postauricular, and anterior cervical lymph nodes are most prominent. In children, the 1st manifestation of rubella is usually the rash, which is variable and not distinctive. It begins on the face and neck as small, irregular pink macules that coalesce, and it spreads centrifugally to involve the torso and extremities, where it tends to occur as discrete macules (Fig. 239-3). About the time of onset of the rash, examination of the oropharynx may reveal tiny, rose-colored lesions (Forchheimer spots) or petechial hemorrhages on the soft palate. The rash fades from the face as it extends to the rest of the body so that the whole body may not be involved at any 1 time. The duration of the rash is generally 3 days, and it usually resolves without desquamation. Subclinical infections are common, and 25-40% of children may not have a rash.

Buy Membership for Pediatrics Category to continue reading. Learn more here